Venous thromboembolic disease reduction with a portable pneumatic compression device.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 18534456.
- Also identified by DOI 10.1016/j.arth.2007.10.030.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study compares a miniaturized, portable, sequential, pneumatic compression device (ActiveCare continuous enhanced circulation therapy [CECT] system) (Medical Compression Systems Ltd, Or Aqiva, Israel), with a nonmobile, nonsequential device on the ability to prevent postoperative deep venous thrombosis (DVT) after joint arthroplasty. All patients were treated with low-molecular-weight heparin, application of 1 of the 2 devices perioperatively, and routine duplex screening. The CECT system had better compliance (83% of the time vs 49%), lower rates of DVT (1.3% compared with 3.6%), reduction in clinically important pulmonary embolism (0 compared to 0.66%), and shorter length of hospital stay (4.2 vs. 5.0 days). The portable CECT system proved significantly more effective than the standard intermittent pneumatic compression when used in conjunction with low-molecular-weight heparin for DVT prevention in high-risk orthopedic patients.
Medical subject headings
- Arthroplasty, Replacement, Hip
- Arthroplasty, Replacement, Knee
- Intermittent Pneumatic Compression Devices
- Venous Thromboembolism
Anatomy
- hip
- knee